Domagrozumab
Domagrozumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Domagrozumab is under investigation in clinical trial NCT01616277 (A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects).
Trade Name | Domagrozumab |
Generic | Domagrozumab |
Domagrozumab Other Names | Domagrozumab, PF-06252616 |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Domagrozumab